secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001193125-24-041440
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene appoints Donna Cochener as SVP and General Counsel
------------------------------------------------------------

- Donna Cochener appointed SVP, General Counsel effective February 15, 2024.
- Base salary set at $370,000 annually; eligible for annual bonus up to 35% of salary.
- Received option grant for 40,000 shares; 25% vests at one year, rest monthly over 36 months.
- Prior consulting agreement terminated upon hire; no written employment agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000119312524041440/0001193125-24-041440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000119312524041440/d699526d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-041440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer